ClinConnect ClinConnect Logo
Search / Trial NCT06578611

Perioperative Smoking Cessation in Elderly Chinese Undergoing Spinal Fusion

Launched by THE SECOND HOSPITAL OF SHANDONG UNIVERSITY · Aug 28, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how to help older Chinese patients stop smoking before and after spinal fusion surgery. Spinal fusion is a procedure that connects two or more bones in the spine to help with pain and improve movement. Because older patients often face more risks after surgery, the goal of this study is to create a special program that supports these patients in quitting smoking, which could lead to better recovery and fewer complications.

To be eligible for this study, participants need to be 65 years or older and planning to have spinal fusion surgery as part of an enhanced recovery after surgery (ERAS) program. They must also agree to take part in the study. Unfortunately, people who have had previous spinal surgery, certain spinal conditions, or who might struggle to understand the study will not be able to participate. Those who join can expect support and guidance tailored to help them quit smoking, which could improve their recovery experience after surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients aged 65 years old or more;
  • 2. Patients who plan to undergo spinal fusion with ERAS program;
  • 3. Patients who agreed to participate in this study.
  • Exclusion Criteria:
  • 1. Patients who cannot understand the study content or have difficulty communicating;
  • 2. Patients with a history of spinal fusion surgery;
  • 3. Patients with spinal fractures, spinal tumor, or spinal infections;
  • 4. Patients with congenital spinal deformity;
  • 5. Patients who were unable to complete at least 6 months of follow-up;
  • 6. Patients with incomplete clinical information.

About The Second Hospital Of Shandong University

The Second Hospital of Shandong University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital is committed to improving patient outcomes by exploring new therapeutic interventions and enhancing existing treatment protocols. With a multidisciplinary approach and a robust infrastructure, the institution facilitates rigorous scientific inquiry while adhering to the highest ethical standards. The Second Hospital of Shandong University actively collaborates with researchers and healthcare professionals to contribute to the global body of medical knowledge and to ensure the delivery of safe and effective care to patients.

Locations

Jinan, Shandong, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported